You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
Sagent PharmaceuticalsFDAMed source confidence · 80%Jun 22, 2026, 10:01 AM UTC · 16d ago

Sagent Pharmaceuticals — FDA Class III (D-0539-2026)

Case File

Sagent Pharmaceuticals is recalling 6,200 vials of a human prescription drug due to contamination. This recall is classified as a Class I recall, indicating a serious risk. The affected lot number is 656412.

Sign in to follow Sagent Pharmaceuticals and get alerts like this
Key Points
  • Sagent Pharmaceuticals is recalling 6,200 vials of a drug.
  • The recall is due to contamination issues.
  • This is classified as a Class I recall.
  • Patients should check for Lot 656412 in their medicine cabinets.
  • Class I recalls typically indicate serious health risks.
Why This Matters

Patients who received Lot 656412 should not use the product due to contamination risks. This recall affects 6,200 vials.

View original filing →
Sign in to follow Sagent Pharmaceuticals and get alerts like this

SIGNA Wire provides informational summaries of official government filings. Not investment advice.